Kebilidi is a one-time gene therapy administered directly to the brain in patients with AADC deficiency, rare genetic ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

Canadian study reveals that women who undergo early menopause are less at risk for asthma than women who experience menopause ...

Member experience, outcomes and medication adherence are the key areas of performance that Medicare Advantage plans should ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

CT scans of the lungs can pick up early-stage lung cancers, but across the nation, less then 20% of those who are eligible ...